Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide

BACKGROUND. Optimal adjuvant management of adult low-grade gliomas is controversial. Recently described tumor classification based on molecular subtype has the potential to individualize adjuvant therapy but has not yet been evaluated as part of a prospective trial. METHODS. Patients aged 18 or olde...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Wahl, Michael, Phillips, Joanna J., Molinaro, Annette M., Lin, Yi, Perry, Arie, Haas-Kogan, Daphne A., Costello, Joseph F., Dayal, Manisha, Butowski, Nicholas, Clarke, Jennifer L., Prados, Michael, Nelson, Sarah, Berger, Mitchel S., Chang, Susan M.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464133/
https://ncbi.nlm.nih.gov/pubmed/27571885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now176
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars